This page requires you to enable JavaScript in your web browser for complete functionality.
Healthwise

Jejunal Atresia


National Organization for Rare Disorders, Inc.

Synonyms

  • Apple Peel Syndrome
  • Christmas Tree Syndrome

Disorder Subdivisions

  • None

Related Disorders List

Information on the following diseases can be found in the Related Disorders section of this report:

  • Duodenal Atresia
  • Multiple Intestinal Atresia

General Discussion

Jejunal Atresia is a rare genetic disorder. Patients with this disorder are born with a partial absence of the fold of the stomach membrane that connects the small intestine to the back wall of the abdomen. As a result, one of the three portions of the small intestine (the jejunal) twists around one of the arteries of the colon called the marginal artery and causes a blockage (atresia). Symptoms in individuals with this disorder include vomiting, a swollen abdomen, and constipation.

Symptoms

Jejunal Atresia is a birth defect in which the fold of the stomach membrane needed to connect the small intestine to the back wall of the abdomen is, in part, absent. As a result, a portion of the small intestine (the jejunal) twists about one of the arteries to the colon. This twisting may be so severe that the artery in question is completely blocked (atrasia). It is sometimes compared to an apple peel in appearance.

Symptoms of Jejunal Atresia may be: vomiting a bitter, yellow-green secretion of the liver (bile); an expanded or swollen upper middle part of the abdomen just below the breastbone (epigastric distension); and an absence of stools after birth.

Causes

Jejunal Atresia may be inherited as an autosomal recessive trait, or it may occur sporadically with no known cause. Human traits, including the classic genetic diseases, are the product of the interaction of two genes, one received from the father and one from the mother. In recessive disorders, the condition does not appear unless a person inherits the same defective gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk of transmitting the disease to the children of a couple, both of whom are carriers for a recessive disorder, is 25 percent. Fifty percent of their children risk being carriers of the disease, but generally will not show symptoms of the disorder. Twenty-five percent of their children may receive both normal genes, one from each parent, and will be genetically normal (for that particular trait). The risk is the same for each pregnancy.

Affected Populations

Jejunal Atresia is a very rare disorder that affects males and females in equal numbers. There have been approximately 57 cases reported in the medical literature.

Related Disorders

Symptoms of the following disorders can be similar to those of Jejunal Atresia. Comparisons may be useful for a differential diagnosis:

Duodenal Atresia is a rare disorder in which there is a blockage of the normal opening or canal (atresia) in the first division of the small intestine (duodenum). There are three types of duodenal atresia. The first division of the small intestine (duodenum) may have a discrepancy in size from one end to the other, the two ends of the duodenum may be connected by a short chord made of fiber-like tissue or there is no chord connecting the blind ends. This malformation in the small intestine causes eighty percent of the patients to vomit a bitter, yellow-green secretion of the liver (bile). Other symptoms of this disorder may be: a swollen upper abdomen; a yellowish coloring of the skin (jaundice); and/or in the pregnant mother of an affected child, an abnormal condition in which there is an excess of fluid around the fetus. The obstruction can be repaired with surgery.

Multiple Intestinal Atresia is a rare disorder in which there are multiple areas of the intestines in which there is an absence of a normal opening or space which causes an intestinal blockage. The atresias typically involve the shortest, widest part of the small intestine that joins the stomach (duodenum), one of the three portions of the small intestine that connects with the duodenum (jejunum), or the portion of the small intestine that opens into the large intestine (ileum), and the rectum. Infants born with this condition vomit continually, have swelling just below the breast bone, a hallow or boat shaped abdomen (scaphoid abdomen), and an empty anal canal. In some cases this disorder may be inherited through an autosomal recessive trait.

Standard Therapies

Jejunal Atresia can be determined prenatally by testing the amniotic fluid. This procedure is suggested in cases when a sibling has been born with the disorder.

Surgery, to repair the intestinal obstruction, is performed as soon as possible after delivery. Parenteral nutrition (food given by a vein or directly to the stomach, but not by mouth) is given for a period of time.

Genetic counseling may be of benefit for patients and their families. Other treatment is symptomatic and supportive.

Investigational Therapies

Research on birth defects and their causes is ongoing. The National Institutes of Health (NIH) is sponsoring the Human Genome Project which is aimed at mapping every gene in the human body and learning why that sometimes malfunction. It is hoped that this new knowledge will lead to prevention and treatment of birth defects in the future.

Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.

For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:

Tollfree: (800) 411-1222
TTY: (866) 411-1010
Email: prpl@cc.nih.gov

For information about clinical trials sponsored by private sources, contact:
www.centerwatch.com

References

TEXTBOOKS
McKusick VA., ed. Online Mendelian Inheritance in Man (OMIM), Baltimore, MD: Johns Hopkins University Press; Entry No: 243600. Creation Date: 6/3/86. Last Edit Date: 11/9/98.

Buyse ML. ed. Birth Defects Encyclopedia. Dover, MA: Blackwell Scientific Publications; For: Center for Birth Defects Information Services, Inc; 1990:993-4.

REVIEW ARTICLE
Lambrecht W, et al., Hereditary multiple atresias of the gastrointestinal tract: report of a case and review of the literature. J Pediatr Surg. 1998;33:794-97.


JOURNAL ARTICLES
Masumoto K, et al., Abnormalities of enteric neurons, intestinal pacemaker cells, and smooth muscle in human intestinal atresia. J Pediatr Surg. 1999;34:1463-68.

Al-Salem AH, et al., Pyloric atresia associated with duodenal and jejunal atresia and duplication. Pediatr Surg Int. 1999;15:512-14.

Tam PK, et al., Implications of antenatal diagnosis of small-intestinal atresia in the 1990s. Pediatr Surg Int. 1999;15:486-87.

Flageole H, et al., The Bianchi procedure in a patient with jejunal atresia. Eur J Pediatr Surg. 1997;7:361-63.

Collins JH, et al., Familial apple peel jejunal atresia: surgical, genetic, and radiographic aspects. Pediatrics 1987;80:540-4.

Olson LM, et al., Identical twins with malrotation and type IV jejunal atresia. J Pediatr Surg 1987; 22:1015-6.

Ahlgren LS, Apple peel jejunal atresia. J Pediatr Surg 1987; 22:451-3.

INTERNET:

http://rarediseases.info.nih.gov/asp/diseases/diseaseinfo.asp?ID=6799

Resources

NIH/National Digestive Diseases Information Clearinghouse
2 Information Way
Bethesda, MD 20892-3570
Tel: (301)654-3810
Fax: (301)907-8906
Tel: (800)891-5389
Email: nddic@info.niddk.nih.gov
Internet: http://www.niddk.nih.gov

Parent Education Network
203 Brookfield Drive
Straford, WI 54484
Tel: (715)687-4551

MUMS (Mothers United for Moral Support, Inc) National Parent-to-Parent Network
150 Custer Court
Green Bay, WI 54301-1243
USA
Tel: (920)336-5333
Fax: (920)339-0995
Tel: (877)336-5333
Email: mums@netnet.net
Internet: http://www.netnet.net/mums/

Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
Tel: (301)519-3194
Fax: (240)632-9164
Tel: (888)205-2311
TDD: (888)205-3223
Email: gardinfo@nih.gov
Internet: http://www.genome.gov/10000409

For a Complete Report

This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). CIGNA members can access the complete report by logging into myCIGNA.com. For non-CIGNA members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.

The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.

It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report

This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.

For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email orphan@rarediseases.org

Last Updated:  8/8/2007
Copyright  1992, 1999, 2007 National Organization for Rare Disorders, Inc.



This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.